未登录

A

Agnès Saint-Raymond

nih eunice kennedy shriver national institute of child health & human development (nichd)

H指数:24

被引数:1,517

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Exclusion by Design: Regulatory Reform and Evolving Frameworks for Clinical Trials in Pregnancy

设计中的排除：妊娠期临床试验的监管改革与演变框架

Pediatric Drugs

IF3.3

2026-09-300

OAAI

Global Cancer Drug Development-A Report From the 2022 Accelerating Anticancer Agent Development and Validation Meeting

JCO GLOBAL ONCOLOGY

IF3

2023-09-014

OAAI

Reliance is key to effective access and oversight of medical products in case of public health emergencies

EXPERT REVIEW OF CLINICAL PHARMACOLOGY

IF3

2022-08-099

PRE

WHO collaborative registration procedure using stringent regulatory authorities' medicine evaluation: reliance in action?

EXPERT REVIEW OF CLINICAL PHARMACOLOGY

IF3

2022-02-1214

OA

Assuring Access to Safe Medicines in Pregnancy and Breastfeeding

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2021-05-0128

OAAI

Reliance: a smarter way of regulating medical products-The IPRP survey

EXPERT REVIEW OF CLINICAL PHARMACOLOGY

IF3

2020-12-2310

OAAI

Remdesivir emergency approvals: a comparison of the US, Japanese, and EU systems

EXPERT REVIEW OF CLINICAL PHARMACOLOGY

IF3

2020-09-2912

OAAI

The European Medicines Agency facilitates access to medicines in low- and middle-income countries

EXPERT REVIEW OF CLINICAL PHARMACOLOGY

IF3

2020-02-1315

OAAI

Are the European Medicines Agency, US Food and Drug Administration, and Other International Regulators Talking to Each Other?

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2019-10-2423

OAAI

Paediatric extrapolation: A necessary paradigm shift

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

IF3

2018-12-1826

OAAI

Availability of paediatric information in European Medicines Agency approvals

LANCET CHILD & ADOLESCENT HEALTH

IF15.5

2018-05-012

PREAI

Enabling Development of Paediatric Medicines in Europe: 10 Years of the EU Paediatric Regulation

PEDIATRIC DRUGS

IF3.3

2017-09-1254

PREAI

Optimizing Research to Speed Up Availability of Pediatric Antiretroviral Drugs and Formulations

CLINICAL INFECTIOUS DISEASES

IF7.3

2017-03-1028

OAAI

Subchondral linear hyperintensity of the femoral head: MR imaging findings and associations with femoro-acetabular joint pathology

DIAGNOSTIC AND INTERVENTIONAL IMAGING

IF8.1

2017-03-015

OAAI

CT of hip prosthesis: New techniques and new paradigms

DIAGNOSTIC AND INTERVENTIONAL IMAGING

IF8.1

2016-07-0128

OAAI

Developments in imaging methods used in hip arthroplasty: A diagnostic algorithm

DIAGNOSTIC AND INTERVENTIONAL IMAGING

IF8.1

2016-07-0120

OAAI

Medicine Safety in Pregnancy and Ambitions for the EU Medicine Regulatory Framework

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2016-05-0911

PREAI

Enhanced Paediatric Pharmacovigilance at the European Medicines Agency: A Novel Query Applied to Adverse Drug Reaction Reports

PEDIATRIC DRUGS

IF3.3

2015-11-2317

PREAI

White spots in pharmaceutical pipelines-EMA identifies potential areas of unmet medical needs

EXPERT REVIEW OF CLINICAL PHARMACOLOGY

IF3

2015-03-235

PREAI

Comparison Between Paediatric and Adult Suspected Adverse Drug Reactions Reported to the European Medicines Agency: Implications for Pharmacovigilance

PEDIATRIC DRUGS

IF3.3

2014-06-0544

PRE